These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 26992699

  • 1. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
    Sirohi S, Aldrich JV, Walker BM.
    Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
    [Abstract] [Full Text] [Related]

  • 2. Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors.
    Kissler JL, Walker BM.
    Neuropsychopharmacology; 2016 Jan; 41(2):560-7. PubMed ID: 26105136
    [Abstract] [Full Text] [Related]

  • 3. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV, Patkar KA, McLaughlin JP.
    Proc Natl Acad Sci U S A; 2009 Oct 27; 106(43):18396-401. PubMed ID: 19841255
    [Abstract] [Full Text] [Related]

  • 4. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.
    Erikson CM, Wei G, Walker BM.
    Neuropharmacology; 2018 Sep 15; 140():162-173. PubMed ID: 30075159
    [Abstract] [Full Text] [Related]

  • 5. The one-two punch of alcoholism: role of central amygdala dynorphins/kappa-opioid receptors.
    Kissler JL, Sirohi S, Reis DJ, Jansen HT, Quock RM, Smith DG, Walker BM.
    Biol Psychiatry; 2014 May 15; 75(10):774-82. PubMed ID: 23611261
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence.
    Walker BM, Koob GF.
    Neuropsychopharmacology; 2008 Feb 15; 33(3):643-52. PubMed ID: 17473837
    [Abstract] [Full Text] [Related]

  • 7. Kappa-opioid receptor antagonism in the nucleus accumbens shell distinguishes escalated alcohol consumption and negative affective-like behavior from physiological withdrawal in alcohol-dependence.
    Lepreux G, Henricks AM, Wei G, Go BS, Erikson CM, Abella RM, Pham A, Walker BM.
    Pharmacol Biochem Behav; 2024 Oct 15; 243():173840. PubMed ID: 39096973
    [Abstract] [Full Text] [Related]

  • 8. Structure-Activity Relationships of the Peptide Kappa Opioid Receptor Antagonist Zyklophin.
    Joshi AA, Murray TF, Aldrich JV.
    J Med Chem; 2015 Nov 25; 58(22):8783-95. PubMed ID: 26491810
    [Abstract] [Full Text] [Related]

  • 9. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests.
    Huang P, Yakovleva T, Aldrich JV, Tunis J, Parry C, Liu-Chen LY.
    Neurosci Lett; 2016 Feb 26; 615():15-20. PubMed ID: 26780565
    [Abstract] [Full Text] [Related]

  • 10. The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety.
    Schank JR, Goldstein AL, Rowe KE, King CE, Marusich JA, Wiley JL, Carroll FI, Thorsell A, Heilig M.
    Addict Biol; 2012 May 26; 17(3):634-47. PubMed ID: 22515275
    [Abstract] [Full Text] [Related]

  • 11. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L, Stahl EL, Lovell KM, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM.
    Neuropharmacology; 2015 Dec 26; 99():131-41. PubMed ID: 26160155
    [Abstract] [Full Text] [Related]

  • 12. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
    Gillett K, Harshberger E, Valdez GR.
    Alcohol; 2013 Aug 26; 47(5):359-65. PubMed ID: 23731692
    [Abstract] [Full Text] [Related]

  • 13. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
    Zhao Y, Joshi AA, Aldrich JV, Murray TF.
    Biomed Pharmacother; 2021 Nov 26; 143():112173. PubMed ID: 34536757
    [Abstract] [Full Text] [Related]

  • 14. Systemic κ-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats.
    Walker BM, Zorrilla EP, Koob GF.
    Addict Biol; 2011 Jan 26; 16(1):116-9. PubMed ID: 20579007
    [Abstract] [Full Text] [Related]

  • 15. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z, Tang Y, Tao H, Li C, Zhang X, Liu Y.
    Neuropharmacology; 2015 Oct 26; 97():259-69. PubMed ID: 26056031
    [Abstract] [Full Text] [Related]

  • 16. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
    Anderson RI, Becker HC.
    Alcohol Clin Exp Res; 2017 Aug 26; 41(8):1402-1418. PubMed ID: 28425121
    [Abstract] [Full Text] [Related]

  • 17. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK, Hourguettes NJ, Sobczak GG, Carlezon WA, Bruchas MR.
    J Neurosci; 2016 Sep 21; 36(38):9937-48. PubMed ID: 27656031
    [Abstract] [Full Text] [Related]

  • 18. Affective cue-induced escalation of alcohol self-administration and increased 22-kHz ultrasonic vocalizations during alcohol withdrawal: role of kappa-opioid receptors.
    Berger AL, Williams AM, McGinnis MM, Walker BM.
    Neuropsychopharmacology; 2013 Mar 21; 38(4):647-54. PubMed ID: 23212453
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S, Lu Y, Schmidt AW, Vanase-Frawley MA, Sawant-Basak A, Miller E, McLean S, Freeman J, Wong S, McLaughlin JP, Verhoest PR.
    J Pharmacol Exp Ther; 2011 Nov 21; 339(2):555-66. PubMed ID: 21821697
    [Abstract] [Full Text] [Related]

  • 20. Dissociable effects of kappa-opioid receptor activation on impulsive phenotypes in wistar rats.
    Walker BM, Kissler JL.
    Neuropsychopharmacology; 2013 Oct 21; 38(11):2278-85. PubMed ID: 23689673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.